Barclays
AEHR icon

Barclays’s Aehr Test Systems AEHR Stock Holding History

Barclays’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
52,214
+7,834
+18% +$251K ﹤0.01% 2372
2025
Q4 		$896K Buy
44,380
+4,160
+10% +$101K ﹤0.01% 3508
2025
Q3 		$1.21M Sell
40,220
-9,123
-18% -$198K ﹤0.01% 3251
2025
Q2 		$638K Buy
49,343
+18,536
+60% +$176K ﹤0.01% 3617
2025
Q1 		$225K Sell
30,807
-14,098
-31% -$156K ﹤0.01% 3981
2024
Q4 		$747K Sell
44,905
-95,620
-68% -$1.27M ﹤0.01% 3573
2024
Q3 		$1.81M Buy
140,525
+30,119
+27% +$435K ﹤0.01% 2937
2024
Q2 		$1.23M Sell
110,406
-15,454
-12% -$180K ﹤0.01% 2474
2024
Q1 		$1.56M Buy
125,860
+78,866
+168% +$1.31M ﹤0.01% 2772
2023
Q4 		$1.25M Buy
46,994
+37,119
+376% +$1.08M ﹤0.01% 3276
2023
Q3 		$451K Sell
9,875
-1,088
-10% -$50.4K ﹤0.01% 2862
2023
Q2 		$452K Sell
10,963
-12,732
-54% -$418K ﹤0.01% 2817
2023
Q1 		$735K Sell
23,695
-97,906
-81% -$3.15M ﹤0.01% 2972
2022
Q4 		$2.44M Buy
121,601
+120,377
+9,835% +$2.58M ﹤0.01% 2119
2022
Q3 		$17K Buy
+1,224
New +$16.5K ﹤0.01% 4109
2022
Q2 		– Sell
-439
Closed -$4K – 4991
2022
Q1 		$4K Buy
+439
New +$5.61K ﹤0.01% 4714
2021
Q4 		– Sell
-26,717
Closed -$365K – 4096
2021
Q3 		$365K Buy
+26,717
New +$192K ﹤0.01% 3337

Other funds holding AEHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's AEHR Position: Q1 2026 in Review

Barclays increased its Aehr Test Systems (AEHR) stake by 18% in Q1 2026, buying an estimated $251K and bringing the position to 52,214 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Barclays first reported a position in AEHR in Q3 2021 and has held it in 17 quarters since. The position peaked at $2.44M in Q4 2022. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • Barclays held 52,214 shares of Aehr Test Systems worth $1.94M as of Q1 2026.
  • Barclays bought 7,834 Aehr Test Systems shares in Q1 2026, an estimated $251K.
  • Aehr Test Systems made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2372 holding.
  • Barclays first reported a position in Aehr Test Systems in Q3 2021 and has held it in 17 quarters since.
  • Barclays's Aehr Test Systems position peaked at $2.44M in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.